Compare AbbVie Inc (ABBV) vs ProShares Ultra Bloomberg Natural Gas ETF (BOIL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
AbbVie Inc vs ProShares Ultra Bloomberg Natural Gas ETF — how do they compare? AbbVie Inc trades at $252.5 (market cap $449.91B), while ProShares Ultra Bloomberg Natural Gas ETF trades at $26.69. The key difference: AbbVie Inc pays a 2.72% dividend while ProShares Ultra Bloomberg Natural Gas ETF pays none, and AbbVie Inc is trading nearer its 52-week high, ProShares Ultra Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| ABBV | BOIL | |
|---|---|---|
Market Cap | $449.91B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $261.07 | $98.62 |
52-Week Low | $184.85 | $24.30 |
Enterprise Value | $513.38B | — |
Dividend Yield | 2.72% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AbbVie (ABBV) trades at $252.61, down 0.84% on the day, with a bullish technical outlook supported by moving averages and strong support at $248. The company reported revenue of $61.16B in 2025, with EPS beats in recent quarters, though net income margin has trended down to 5.79%. Key growth drivers Skyrizi and Rinvoq are offsetting Humira declines, with positive clinical updates like the Phase 2 ELAHERE data at SGO 2026.
The stock offers a compelling buy case with a consensus price target of $266.33 (5.4% upside) and strong analyst support (68% buy ratings). However, risks include patent cliffs in the 2030s, high debt levels, and margin pressure. Dividend growth is recovering, supporting income investors, but execution on pipeline assets remains critical for sustained expansion.
BOIL trades at $26.65, up 0.79% today, but technical indicators signal a bearish trend with 14 sell signals versus 1 buy. The stock recently underwent a 1:2 split on May 28, 2026. Natural gas futures volatility, driven by weather forecasts and LNG demand, heavily influences price action. Key support sits at $25-26, with resistance at $27-28.
Outlook remains cautious due to technical weakness and reliance on volatile commodity prices. Investment opportunity exists for tactical traders betting on natural gas price swings, but risks include contango erosion and weather-dependent demand. Long-term value erosion is a significant concern given the ETF's structure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbbVie Inc
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.
Read more on ABBV →About ProShares Ultra Bloomberg Natural Gas ETF
BOIL is a leveraged ETF that seeks to provide two times (2x) the daily performance of the Bloomberg Natural Gas Subindex. It uses futures contracts to offer magnified exposure to natural gas price movements.
Read more on BOIL →
